Our most comprehensive multi-peptide research formulation — four compounds, one sterile vial.
KLOW is the flagship of the blend range — the GLOW formulation with a fourth peptide added. If GLOW is recovery-plus-skin, KLOW adds an anti-inflammatory dimension on top.
What’s in it
KLOW combines four compounds: GHK-Cu, BPC-157, TB-500 and KPV. The first three are the GLOW trio; KPV is the new addition — a small tripeptide fragment derived from α-MSH that’s studied specifically for its anti-inflammatory properties.
That KPV addition is the whole point of KLOW: it brings an inflammation-focused angle to the established skin-and-recovery base.
Why it’s the flagship
With four well-studied components in a single balanced vial, KLOW is the most comprehensive research formulation we supply — built for protocols that want repair, skin and anti-inflammatory pathways represented together. As always, each component is manufactured to ≥99% purity before blending.
Where it sits
KLOW sits at the top of the blend ladder: two-peptide → three-peptide GLOW → four-peptide KLOW.
Handling in the lab
Lyophilised, reconstituted with bacteriostatic water and kept cold. Janoshik verified — certificate on the product page.
In the catalogue
KLOW Blend
Stocked in our UK warehouse at ≥99% HPLC purity, Janoshik independently tested.
